Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microbax is an India-based biotechnology company focused on probiotics, microbial consortia, and related biotechnological products and services. The company develops and manufactures solutions spanning human health, animal health, aquaculture, agriculture, vector control, and environmental applications. Its capabilities include DSIR-recognized R&D, strain isolation and characterization, fermentation process development, formulation, quality testing, and contract/OEM manufacturing. Microbax appears to operate primarily as a commercial microbial-products and industrial biotechnology business rather than a clinical-stage therapeutics developer. Its portfolio includes probiotics, prebiotics, synbiotics, biofertilizers, biocontrol products, and enzyme-based microbial solutions for domestic and international partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microbax.